New therapeutic perspectives on protein-bound uremic toxins in chronic kidney disease

被引：5
|
作者：
Malyszko, Jolanta [1 ,2 ]
机构：
[1] Med Univ, Dept Nephrol 2, PL-15276 Bialystok, Poland
[2] Hypertens Dialysis Unit, PL-15276 Bialystok, Poland
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2014年 / 18卷 / 02期
关键词：
AST-120; chronic kidney disease; indoxyl sulfate; uremic toxins; CHRONIC-RENAL-FAILURE; P-CRESOL SULFATE; INDOXYL SULFATE; DIALYZER MEMBRANE; ORAL ADSORBENT; REMOVAL; AST-120; HEMODIALYSIS; PROGRESSION; SOLUTES;
D O I：
10.1517/14728222.2014.860966
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The uremic syndrome is a complex mosaic of clinical alterations that may be attributable to one or more of these different solutes. Uremic symptoms in patients with chronic kidney disease are primarily a consequence of inadequate removal and subsequent accumulation of organic products normally metabolized or excreted by the kidney.
引用
收藏
页码：109 / 113
页数：5
相关论文
共 50 条
  • [31] Protein-Bound Uremic Toxins Lowering Effect of Sevelamer in Pre-Dialysis Chronic Kidney Disease Patients with Hyperphosphatemia: A Randomized Controlled Trial
    Takkavatakarn, Kullaya
    Puapatanakul, Pongpratch
    Phannajit, Jeerath
    Sukkumme, Warumphon
    Chariyavilaskul, Pajaree
    Sitticharoenchai, Patita
    Leelahavanichkul, Asada
    Katavetin, Pisut
    Praditpornsilpa, Kearkiat
    Eiam-Ong, Somchai
    Susantitaphong, Paweena
    TOXINS, 2021, 13 (10)
  • [32] Protein-bound Uremic Toxins, Inflammation and Oxidative Stress: A Cross-sectional Study in Stage 3-4 Chronic Kidney Disease
    Rossi, Megan
    Campbell, Katrina L.
    Johnson, David W.
    Stanton, Tony
    Vesey, David A.
    Coombes, Jeff S.
    Weston, Kassia S.
    Hawley, Carmel M.
    McWhinney, Brett C.
    Ungerer, Jacobus P. J.
    Isbel, Nicole
    ARCHIVES OF MEDICAL RESEARCH, 2014, 45 (04) : 309 - 317
  • [33] Protein-bound uremic toxins (PBUTs) in chronic kidney disease (CKD) patients: Production pathway, challenges and recent advances in renal PBUTs clearance
    Daneshamouz, Sana
    Eduok, Ubong
    Abdelrasoul, Amira
    Shoker, Ahmed
    NANOIMPACT, 2021, 21
  • [34] New approaches to the removal of protein-bound toxins from blood plasma of uremic patients
    Sarnatskaya, V. V.
    Yushko, L. A.
    Sakhno, L. A.
    Nikolaev, V. G.
    Nikolaev, A. V.
    Grinenko, D. V.
    Mikhalovsky, S. V.
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2007, 35 (03): : 287 - 308
  • [35] Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease
    Faria, Monica
    DePinho, Maria Norberta
    TRANSLATIONAL RESEARCH, 2021, 229 : 115 - 134
  • [36] Accumulation of protein-bound uremic toxins: the kidney remains the leading culprit in the gut-liver-kidney axis
    Jourde-Chiche, Noemie
    Burtey, Stephane
    KIDNEY INTERNATIONAL, 2020, 97 (06) : 1102 - 1104
  • [37] EFFECTS OF HEMOPERFUSION ON PROTEIN-BOUND UREMIC TOXINS IN PATIENTSWITH MAINTENANCE HEMODIALYSIS
    Lun, Lide
    Zhang, Hong
    Li, Xinlun
    Gao, Zuo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 228 - 228
  • [38] Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome
    Lekawanvijit, Suree
    Kompa, Andrew R.
    Krum, Henry
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2016, 311 (01) : F52 - F62
  • [39] Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins
    Guo, Jingbin
    Lu, Lu
    Hua, Yue
    Huang, Kevin
    Wang, Ian
    Huang, Li
    Fu, Qiang
    Chen, Aihua
    Chan, Paul
    Fan, Huimin
    Liu, Zhong-Min
    Wang, Bing Hui
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2017, 313 (01): : H1 - H13
  • [40] Preparation and Property of A Novel Hemoperfusion Adsorbent For Protein-bound Uremic Toxins
    Liu Yunhong
    Peng Xinyan
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2021, 42 (06): : 1952 - 1964
12345